The DOD-CPDR is a comprehensive research program to
study prostate cancer and prostate disease in the triservice military
health care system. Established in 1991 (Public Law 102-172), the CPDR
has received funding from Congress through the U.S. Army Medical Research
and Materiel Command since 1992.
Below we illustrate the program structure and list
the core programs within CPDR.
Recognizing
that too few men have participated in clinical trials in the past, this
Program will make state-of-the-art research trials available to deserving
military health beneficiaries. The Program is open to all beneficiaries
worldwide.
The
CPDR Multicenter National Database contains clinical data on 19,000
patients from nine military and one non-military medical center from
around the US. This database has been used to examine patterns in prostate
cancer treatment, progression, and survival.
The
Basic Science Research Program of the CPDR is a multi-disciplinary research
endeavor. The area of research efforts are; prostate cancer specific
gene alterations, hormonal mechanisms in prostate cancer, development
of novel cell culture models, novel bio-markers and to identify effective
therapeutic targets.
The
goal of the CPDR Biorepository is to support translational studies at
CPDR, and complement efforts of other investigators in the field, by
providing human biologic specimens unique to CPDR.
CPDR
established a large network of long-term academic collaborations helping
our program with additional special expertise. Collaborations with the
pharmaceutical and biotech industry are focused around patented CPDR
discoveries and technologies to accelerate their translation into potential
clinical applications.
The
postdoctoral training program has been a great success and has continued
to grow since its inception. The Department of Surgery, USUHS, CPDR
trains residents, post-doctoral fellows, graduate students, undergraduates
and high school students.
